What does CUSIP 86150R107 represent in this 13F holders report?

CUSIP 86150R107 is the security identifier for STOK - Stoke Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held STOK - Stoke Therapeutics, Inc. - Common Stock in Q2 2020?

70 institutional investors reported STOK - Stoke Therapeutics, Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Stoke Therapeutics, Inc. - Common Stock (STOK)

CUSIP: 86150R107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 57,529,259
Total 13F shares: 34,945,268
Share change: +387,561
Total reported value: $824,517,432
Price per share: $23.83
Number of holders: 70
Value change: +$9,797,711
Number of buys: 26
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 86150R107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ATP Life Science Ventures, L.P.	13F	Company	29%	16,786,713	$384,416,000	—	31 Mar 2020	13F
RTW INVESTMENTS, LP	13F	Company	6.2%	3,544,248	$81,163,000	—	31 Mar 2020	13F
Redmile Group, LLC	13F	Company	3.8%	2,165,938	$49,600,000	—	31 Mar 2020	13F
Cormorant Asset Management, LP	13F	Company	3%	1,709,765	$39,154,000	—	31 Mar 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	2.9%	1,686,747	$38,627,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	2.4%	1,370,786	$31,391,000	—	31 Mar 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.9%	1,119,963	$25,647,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	1.4%	830,400	$19,016,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	1.4%	795,990	$18,229,000	—	31 Mar 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.2%	671,978	$15,388,000	—	31 Mar 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.92%	530,589	$12,150,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.81%	466,347	$10,679,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.74%	427,522	$9,790,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.51%	294,281	$6,739,000	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	0.43%	250,000	$5,725,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.35%	202,563	$4,639,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.35%	201,137	$4,607,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.35%	200,000	$4,580,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.32%	185,856	$4,256,000	—	31 Mar 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	0.32%	182,461	$4,178,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.23%	131,180	$3,004,000	—	31 Mar 2020	13F
Casdin Capital, LLC	13F	Company	0.21%	120,000	$2,748,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.2%	113,493	$2,599,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	86,110	$1,972,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.12%	70,403	$1,613,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.1%	57,262	$1,311,000	—	31 Mar 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.05%	27,254	$624,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	25,853	$592,000	—	31 Mar 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.04%	22,279	$510,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	21,210	$486,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	20,956	$480,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	20,218	$463,000	—	31 Mar 2020	13F
Birchview Capital, LP	13F	Company	0.03%	20,000	$458,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	18,865	$432,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	17,300	$396,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.03%	15,600	$357,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	14,470	$331,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	14,100	$323,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	12,861	$295,000	—	31 Mar 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.02%	10,603	$243,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.02%	10,069	$231,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	9,600	$220,000	—	31 Mar 2020	13F
MetLife Investment Management, LLC	13F	Company	0.01%	7,812	$178,895	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0.01%	7,192	$165,000	—	31 Mar 2020	13F
SG Americas Securities, LLC	13F	Company	0.01%	6,783	$155,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.01%	6,198	$142,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	5,910	$135,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	5,848	$134,000	—	31 Mar 2020	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0.01%	5,525	$126,523	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	5,505	$126,000	—	31 Mar 2020	13F

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q2 2020

As of 30 Jun 2020, Stoke Therapeutics, Inc. - Common Stock (STOK) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,945,268 shares. The largest 10 holders included Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, Redmile Group, LLC, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., FEDERATED HERMES, INC., and FMR LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.